Characterization of p57, a Stage-Specific Antigen of Pneumocystis murina

Pneumocystis has a large multicopy gene family encoding proteins related to the major surface glycoprotein (Msg), whose functions are largely unknown. We expressed one such protein of Pneumocystis murina, p57, which is encoded by 3 highly conserved genes, and demonstrated by immunoblot that immunocompetent mice that were immunized with crude Pneumocystis antigens or that had cleared Pneumocystis infection developed antibodies to p57. Using hyperimmune anti-p57 serum combined with immunolabeling, we found that p57 was expressed by small trophic forms and intracystic bodies, whereas it was not expressed on larger trophic forms or externally by cysts. Expression of p57 and Msg by trophic forms was largely mutually exclusive. Treatment of infected animals with caspofungin inhibited cyst formation and markedly decreased p57 expression. While p57 expression was seen in immunocompetent mice infected with Pneumocystis, immunization with recombinant p57 did not result in altered cytokine expression by lymphocytes or in diminished infection in such mice. Thus, p57 appears to be a stage-specific antigen of Pneumocystis that is expressed on intracystic bodies and young trophic forms and may represent a mechanism to conserve resources in organisms during periods of limited exposure to host immune responses.

[1]  J. Kovacs,et al.  Pulmonary Interleukin-17-Positive Lymphocytes Increase during Pneumocystis murina Infection but Are Not Required for Clearance of Pneumocystis , 2017, Infection and Immunity.

[2]  Brad T. Sherman,et al.  β-Glucans Are Masked but Contribute to Pulmonary Inflammation During Pneumocystis Pneumonia. , 2016, The Journal of infectious diseases.

[3]  Brad T. Sherman,et al.  Genome analysis of three Pneumocystis species reveals adaptation mechanisms to life exclusively in mammalian hosts , 2016, Nature Communications.

[4]  J. Kovacs,et al.  Pneumocystis encodes a functional endo-β-1,3-glucanase that is expressed exclusively in cysts. , 2015, The Journal of infectious diseases.

[5]  M. Pagni,et al.  Comparative Genomics Suggests Primary Homothallism of Pneumocystis Species , 2015, mBio.

[6]  Alexandros Stamatakis,et al.  RAxML version 8: a tool for phylogenetic analysis and post-analysis of large phylogenies , 2014, Bioinform..

[7]  J. Kovacs,et al.  Expression of Pneumocystis jirovecii major surface glycoprotein in Saccharomyces cerevisiae. , 2013, The Journal of infectious diseases.

[8]  J. Kovacs,et al.  Discordant antibody and cellular responses to Pneumocystis major surface glycoprotein variants in mice , 2012, BMC Immunology.

[9]  A. Morris,et al.  Colonization by Pneumocystis jirovecii and Its Role in Disease , 2012, Clinical Microbiology Reviews.

[10]  Sean R. Eddy,et al.  Accelerated Profile HMM Searches , 2011, PLoS Comput. Biol..

[11]  J. Kovacs,et al.  Characterization of the meiosis-specific recombinase Dmc1 of pneumocystis. , 2010, The Journal of infectious diseases.

[12]  J. Kovacs,et al.  Evolving health effects of Pneumocystis: one hundred years of progress in diagnosis and treatment. , 2009, JAMA.

[13]  M. Pottier,et al.  The Pneumocystis life cycle. , 2009, Memorias do Instituto Oswaldo Cruz.

[14]  Geoffrey J. Barton,et al.  Jalview Version 2—a multiple sequence alignment editor and analysis workbench , 2009, Bioinform..

[15]  A. Limper,et al.  Current insights into the biology and pathogenesis of Pneumocystis pneumonia , 2007, Nature Reviews Microbiology.

[16]  J. Kovacs,et al.  Quantitative real-time polymerase chain-reaction assay allows characterization of pneumocystis infection in immunocompetent mice. , 2004, The Journal of infectious diseases.

[17]  Robert C. Edgar,et al.  MUSCLE: multiple sequence alignment with high accuracy and high throughput. , 2004, Nucleic acids research.

[18]  John P. Huelsenbeck,et al.  MRBAYES: Bayesian inference of phylogenetic trees , 2001, Bioinform..

[19]  Dennis Schmatz,et al.  Efficacy of MK-991 (L-743,872), a Semisynthetic Pneumocandin, in Murine Models ofPneumocystis carinii , 1998, Antimicrobial Agents and Chemotherapy.

[20]  R. Morris,et al.  Zymolyase Treatment Exposes p55 Antigen of Pneumocystis carinii , 1998, The Journal of eukaryotic microbiology.

[21]  S. Sunkin,et al.  Genes Encoding Antigenic Surface Glycoproteins in Pneumocystis from Humans , 1993, The Journal of eukaryotic microbiology.

[22]  J. Kovacs,et al.  Multiple genes encode the major surface glycoprotein of Pneumocystis carinii. , 1993, The Journal of biological chemistry.

[23]  D. Schmatz,et al.  Treatment and prevention of Pneumocystis carinii pneumonia and further elucidation of the P. carinii life cycle with 1,3-beta-glucan synthesis inhibitor L-671,329. , 1991, The Journal of protozoology.

[24]  W. Martin,et al.  Pneumocystis carinii attachment to cultured lung cells by pneumocystis gp 120, a fibronectin binding protein. , 1991, The Journal of clinical investigation.

[25]  D. Schmatz,et al.  Treatment of Pneumocystis carinii pneumonia with 1,3-beta-glucan synthesis inhibitors. , 1990, Proceedings of the National Academy of Sciences of the United States of America.

[26]  J. Kovacs,et al.  Identification of antigens and antibodies specific for Pneumocystis carinii. , 1988, Journal of immunology.

[27]  J. Stringer Antigenic Variation in Pneumocystis 1 , 2007, The Journal of eukaryotic microbiology.

[28]  J. Kovacs,et al.  Purification and characterization of a major human Pneumocystis carinii surface antigen. , 1991, The Journal of clinical investigation.

[29]  松本 芳嗣 Sporogony in Pneumocystis carinii : synaptonemal complexes and meiotic nuclear divisions observed in precysts , 1985 .